About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
TAVR (Transcatheter Aortic Valve Replacement)
By
Tufts Medical Center
November 2, 2017
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
Boston Scientific
Cerebral Embolic Protection: Data and Limitations in the Current Era…
Fri, May 8, 2020
Faculty:
Carlos Sanchez
,
Boston Scientific
,
Amar Krishnaswamy
,
Kendra Grubb
Boston Scientific
Cerebral Embolic Protection and the Low Risk TAVR Patient
Mon, Nov 1, 2021
Faculty:
Boston Scientific
,
James Harvey
,
Suzanne Baron
Boston Scientific
Lifetime Management and Cerebral Embolic Protection in TAVR
Thu, Apr 14, 2022
Faculty:
Thomas Waggoner
,
Boston Scientific
,
Kendra Grubb
24:31
Vinod Thourani
How Do I Treat Low Gradient & Severe Aortic Stenosis?
12:45
Miami Valves
Suprasternal Direct Aortic Approach TAVR Avoid Sternotomy and Thraco…
Feat.
A. Kiser
13:53
JenaValve
TVT 2021 - Characterizing the Transcatheter Need for High-Risk Sever…
Feat.
T. Vahl,
V. Thourani,
M. Mack,
H. Treede
18:36
JenaValve
London Valves 2021 Symposium - Live Case: Treatment of Pure Aortic R…
Feat.
N. Van Mieghem,
A. Baumbach,
T. Vahl,
T. Rudolph,
M. Adam,
H. Treede
17:50
JenaValve
TVT 2021 - Case Presentation: High-Risk Severe AR Treated with a Com…
Feat.
T. Vahl,
T. Cahill,
M. Mack
91:27
JenaValve
TVT 2021 – High-Risk Severe AR with TAVR
Feat.
M. Mack,
T. Vahl,
V. Thourani,
O. Ben-Yehuda,
D. Daniels,
L. Ranard,
N. Hamid,
T. Cahill,
H. Treede,
D. Kereiakes
56:22
JenaValve
Aortic Regurgitation Webinar: A Disease State Review, Current Treatm…
Feat.
V. Thourani,
J. McCabe,
M. Russo
17:08
JenaValve
TVT 2021 - The Future Role of TAVR in Aortic Regurgitation Therapy: …
Feat.
T. Vahl,
O. Ben-Yehuda,
M. Mack
16:01
JenaValve
Aortic Regurgitation Webinar - Q&A on TAVR for Aortic Regurgitat…
Feat.
V. Thourani,
M. Russo,
J. McCabe
13:59
JenaValve
TVT 2021 - Case Presentation: High-Risk Severe AR Treated with a Jen…
Feat.
T. Vahl,
L. Ranard,
M. Mack
09:48
American College of Cardiology
PARTNER 3 Trial: Should TAVR or SAVR Be Performed Among Low-risk Pat…
Feat.
D. Adams,
V. Fuster,
R. Mehran,
A. Lala-Trindade,
V. Reddy
15:19
JenaValve
Aortic Regurgitation Webinar - Do Current Treatment Options Meet the…
Feat.
M. Russo
11:39
JenaValve
Aortic Regurgitation Webinar - The ALIGN-AR Trial: Novel TAVR Device…
Feat.
J. Mccabe
01:51
JenaValve
ALIGN-AR Call to Action - Refer Severe, Symptomatic AR Patients with…
Feat.
V. Thourani
13:27
JenaValve
London Valves 2021 Symposium - Progression, Guidelines, and Assessm…
Feat.
N. Van Mieghem,
A. Baumbach,
T. Vahl,
T. Rudolph,
M. Adam,
H. Treede
12:45
Scripps Health: 2019 Eighth Annual Structural Heart Intervention and Imaging
Cerebral Protection for TAVR: When and Why
Feat.
D. Rizik
12:36
JenaValve
TVT 2021 - Updates From the ALIGN-AR Trial: TAVR for Aortic Regurgit…
Feat.
T. Vahl,
M. Mack
05:17
Boston Scientific
Cerebral Embolic Protection with SENTINEL: Technology Overview and …
Feat.
H. Gada
29:58
San Diego Cardiovascular Interventions (SDCI) 2019
TAVR: Are We Ready for the Low Risk Patients?
Feat.
R. Jauhar
18:55
New York Transcatheter Valves 2019
Valvular Heart Disease and Aortic Stenosis Management in 2020: What …
Feat.
R. Nishimura
